Wellmind Health is a REMS-certified Spravato provider. If standard antidepressants haven't worked, this FDA-approved nasal treatment is administered and monitored on-site by our psychiatric team — and for most patients, insurance covers it.
You've tried at least two antidepressants at adequate doses without enough relief. Spravato works on a different pathway than pills you've likely already tried.
For major depressive disorder with acute suicidal thoughts or behavior, Spravato is FDA-approved to be used alongside an oral antidepressant.
That's what the initial evaluation is for. Our psychiatric team reviews your history and treatment record before recommending anything.
A novel mechanism targeting glutamate receptors — the brain's most abundant messenger system.
Spravato blocks NMDA receptors, increasing glutamate — the brain's most abundant chemical messenger — creating a broader impact on more brain cells simultaneously.
Unlike traditional antidepressants that take weeks, Spravato can begin reducing depressive symptoms within hours to days of the first treatment session.
Research suggests esketamine may reverse stress-related damage in the brain, promoting new neural connections and potentially counteracting the neurotoxic effects of chronic depression.
Unlike a pill you take at home, Spravato is dosed and monitored in our office. Here's the real timeline, start to finish.
Blood pressure and a quick symptom check before dosing.
Nasal spray, given under direct staff supervision.
You rest in a comfortable room while we track vitals and how you're feeling, per REMS protocol.
Cleared once blood pressure and alertness are back to baseline.
You can't drive yourself the day of treatment — we help you plan for that in advance.
We've completed the full federal certification required to prescribe and administer esketamine on-site.
We handle the prior authorization process so you're not stuck on hold with your insurer.
Every treatment plan is overseen by a licensed psychiatric mental health nurse practitioner, not a technician following a script.
The provider who evaluates you is the same team monitoring your sessions.
Spravato (esketamine) is FDA-approved, and its intranasal formulation is what's studied and covered for treatment-resistant depression and MDD with suicidal ideation. IV ketamine is often used off-label and is typically self-pay. We offer both, and your evaluation will point you to the right one.
Most major plans in Utah cover Spravato for the approved diagnoses, though prior authorization is usually required. We verify your specific benefits before you commit to anything.
No referral is required to schedule an evaluation. If you're already seeing a therapist or PCP, we're happy to coordinate care with them.
A full psychiatric evaluation to confirm diagnosis and treatment history, review of any prior medications, and a conversation about whether Spravato is an appropriate next step.
Leave your info and our team will verify your specific plan and call you back — usually the same business day.